home / stock / optn / optn news


OPTN News and Press, OptiNose Inc. From 11/20/19

Stock Information

Company Name: OptiNose Inc.
Stock Symbol: OPTN
Market: NASDAQ
Website: optinose.com

Menu

OPTN OPTN Quote OPTN Short OPTN News OPTN Articles OPTN Message Board
Get OPTN Alerts

News, Short Squeeze, Breakout and More Instantly...

OPTN - Optinose Announces Proposed Public Offering of Common Stock

YARDLEY, Pa., Nov. 20, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that it and certain selling stockholders intend to offer and sell shares of its common stock in...

OPTN - Optinose, Inc.'s (OPTN) CEO Peter Miller on Q3 2019 Results - Earnings Call Transcript

Optinose, Inc. (OPTN) Q3 2019 Results Earnings Conference Call November 12, 2019, 4:30 PM ET Company Participants Jonathan Neely - Vice President, Investor Relations Peter Miller - Chief Executive Officer Ramy Mahmoud - President and COO Keith Goldan - Chief Financial Officer ...

OPTN - OptiNose, Inc. (OPTN) Q3 2019 Earnings Call Transcript

Image source: The Motley Fool. OptiNose, Inc.   (NASDAQ: OPTN) Q3 2019 Earnings Call Nov 12, 2019 , 4:30 p.m. ET Operator Continue reading

OPTN - OptiNose EPS in-line, beats on revenue

OptiNose (NASDAQ: OPTN ): Q3 GAAP EPS of -$0.69 in-line. More news on: OptiNose, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

OPTN - Optinose Reports Third Quarter 2019 Financial Results and Recent Operational Highlights

XHANCE net revenue grew 30% to $8.7 million from second to third quarter 2019 XHANCE prescriptions increased 27% from second to third quarter 2019 Company expects XHANCE net revenues for 2019 to be in the range of $30 - $33 million Conference call and webcast to be held toda...

OPTN - 4 RNA Therapy Stocks For A Biotech Portfolio

Biotech Pulse Biotech finally has a pulse. The improving appetite for risk has resuscitated the moribund biotechs and pharma (biopharma) groups. The Nasdaq Biotech ( IBB ) and the S&P Biotech ( XBI ) indexes have begun their advance from their year-to-date lows recorded earlier in Octo...

OPTN - Optinose to Report Third Quarter 2019 Financial Results and Corporate Updates on November 12, 2019

YARDLEY, Pa., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will release financial results for the third quarter 2019, after market close o...

OPTN - Optinose Appoints Michael Richardson to New Position of Vice President, Business Development

YARDLEY, Pa., Oct. 04, 2019 (GLOBE NEWSWIRE) --   Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported the creation of a new role of Vice President, Business Development and appointment of ...

OPTN - Spotlight On Microsoft, Tesla And Xilinx (Stocks To Watch Podcast)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (...

OPTN - Stocks To Watch: Spotlight On Microsoft, Tesla And Xilinx

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Previous 10 Next 10